ANOFE 4000 IU is an injectable prescription medication containing Recombinant Human Erythropoietin Alfa . it belongs to a class of erythropoietin Alfa . it belongs to the class of ESA and works by stimulating bone marrow to produce more red blood cells. It is primarily used to treat anemia .

WHAT IS  ANOF 4000 IU INJECTION PFS?

ANOFE 4000 IU is a synthetic medication classified as ESA . its active ingredient is Recombinant Human Erythropoietin Alfa (Epotin alfa).it works by mimicking the natural hormone, erythropoietin ,stimulating the bone marrow to produce more red blood cells. It is primarily used to treat anemia associated with chronic kidney disease (CKD) , cancer chemotherapy and HIV treatments .

Key classification:

.Drug class: Erythropoiesis-stimulating Agent (ESA)

• Therapeutic use: Anti-anemic

• Biochemical Type: Glycoprotein hormone

• Prescription status: prescription –only medication .

• Available strength : 4000 IU/1Ml

WHAT ARE THE MEDICAL USES OF ANOFE 4000 IU INJECTION ?

Medical uses of ANOFE 4000 IU injection are:

A) Chronic kidney Disease (CKD) –related Anemia

ANOFE 4000 IU injection is widely prescribed to treat anemia caused by chronic kidney disease (CKD) .it corrects hemoglobin levels, alleviates fatigue, and reduces the need for blood transfusion. It is used in the following ways in chronic kidney disease (CKD):

1) Treatment of Anemia in dialysis and non-dialysis patients

ANOFE 4000IU is widely used to manage symptomatic anemia in chronic kidney disease (CKD) in patients –both on dialysis and non-dialysis –as well as those undergoing chemotherapy or HIV treatments. When the kidneys are damaged (as in CKD) , they fail to produce enough natural erythropoietin, leading to low RBC counts. ANOFE act as a synthetic replacement for this hormone.

• Dialysis patients: ANOFE 4000IU helps reduce fatigue , increases energy and maintain target hemoglobin levels .

• Non-Dialysis patients : it is typically injected under the skin (subcutaneously) into the abdomen ,thigh or upper arm to steadily improve red blood cell production.

2) Improving hemoglobin levels

ANOFE 1000 IU –typically referring to 1000mg dose of intravenous (IV) iron is used for treating Iron deficiency Anemia (IDA) . This treatment is designed to replenish iron stores, helping the body produce red blood cells and increase hemoglobin (HB) levels. An increase in HB is often observed within 1 to 2 weeks, with continued improvements typically occurring in weeks following treatment. Healthcare provider monitor patients for a short period afterward to ensure there are no adverse reactions.

B) Chemotherapy –induced Anemia

ANOF 1000IU is an intravenous iron formulation used to manage chemotherapy –induced anemia (CIA). Administered as a large single -dose infusion (1000mg), it bypasses inflammation –induced iron blockades to safely restore hemoglobin levels ,alleviate fatigue ,and reduce Reliance on blood transfusions. It is generally well-tolerated, though mild ,transient side effects can occur ,such as a metallic taste, nausea, or localized injection site reactions . while ANOF 1000IU is highly effective at replenishing iron, the oncologist may sometimes use it in conjunction with other therapies depending on the severity of anemia.

1) Supportive care for cancer patients

Supportive care in oncology involves the management of side effects-like nausea, pain and fatigue caused by cancer and its treatment . in medical context ,’’ANOF 1000’’ refers to an Absolute Neutrophil Count (ANC) of less than 1000cells/mm. when a patient ANC drops below 1000,they are considered neutropenic, which significantly increases the rise of severe infections and often requires adjusting or delaying cancer treatment.

2) Reducing the need of blood transfusion

A single 1,000mg intravenous (IV) iron infusion effectively treats iron-deficiency anemia and significantly reduces the need for allogenic blood transfusion . by quickly replenishing the body’s iron stores, it enables the bone marrow to rapidly produce new red blood cells and increases hemoglobin levels.

C) Anemia associated with chronic diseases

ANOFE 4000IU is used to treat anemia by stimulating the bone marrow to produce red blood cells. It is primarily indicated for anemia associated with chronic kidney disease (CKD) , cancer chemotherapy and HIV treatments .

1) Management of Anemia caused by inadequate erythropoietin production

ANOFE 4000 IU stimulates bone marrow stem cells to produce RBC ,replacing missing erythropoietin . it is used to manage caused by chronic kidney disease (CKD), chemotherapy and HIV therapies by increasing hemoglobin and oxygen-carrying capacity . Hemoglobin levels are monitored during treatment to ensure they remain within a targeted range , as levels that rise too quickly or become too high can increase risk.

2) Improving oxygen carrying capacity of the blood.

ANOFE 4000 IU stimulates bone marrow stem cells to produce red blood cells. By elevating hemoglobin and red cell counts ,it significantly improve the blood’s oxygen-carrying capacity ,relieving anemia related fatigue and shortness of breath. It is primarily prescribed to treat chronic anemia associated with specific medical conditions .

D) Preoperative Anemia management

ANOFE 4000IU stimulate the bone marrow to produce red blood cells . in preoperative anemia management ,it is used to boost hemoglobin levels and reduce the need for allogenic blood transfusions. Its goal is to increase hemoglobin levels and reduce the need for allogenic blood transfusions.

1) Increasing Red blood cell counts before surgery

ANOFE 4000 IU contains recombinant human erythropoietin , which stimulates the bone marrow . It is used to quickly raise the hemo to produce red blood cells before major effective surgery globin levels and prevent the need for blood transfusions. It prompt the bone marrow to accelerate the creation of healthy red blood cells. Elevating hemoglobin prior to planed operations lowers the likelihood that one will need an allogenic blood transfusion.

2) Reducing transfusion requirements

ANOFE 4000IU is widely used to manage severe anemia caused by chronic kidney disease (CKD), cancer chemotherapy or HIV treatment as well as before major orthopedic surgeries. While it is highly effective at increasing hemoglobin levels ,the drug can cause a rapid rise in blood pressure . because of this, it requires a close medical management .

Conclusion

ANOFE 4000IU injection is a synthetic man-made protein that mimics the body’s natural hormone responsible for red blood cell production . it is primarily prescribed to treat anemia caused by chronic kidney disease, cancer chemotherapy or HIV treatments . while generally safe when expertly prescribed, it carries a risk of elevating blood pressure and causing blood clots. Regular monitoring of blood pressure ,iron stores and red blood cell count is mandatory .

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS ANOFE 4000IU INJECTION USED FOR?

ANOFE 4000 IU is a medication used to treat anemia .it stimulate the bone marrow to produce more red blood cells , which improves the oxygen –carrying capacity of the blood and relives symptoms of fatigue and weakness.

QUESTION: HOW DOES EPOTEIN ALFA WORK?

Epotein alfa is a man-made version of the natural hormone erythropoietin (EPO) , which is produced by the kidneys. It is ESA , that treats anemia by signaling the bone marrow to produce more red blood cells.

QUESTION: HOW SOON CAN IMPROVEMENT IN ANEMIA BE EXPECTED?

Improvement in anemia with ANOF 4000 IU is generally noticeable within 2 to 4 weeks . Because this medication works by signaling the bone marrow to produce new red blood cells ,it takes time for these cells to mature and circulate in ones bloodstream .

REFRENCES:

1)https://m.indiamart.com/proddetail/anfoe-4000-injection-22016830862.html

2)https://pharmeasy.in/online-medicine-order/anfoe-4000iu-injection-16137